Mechanisms of demyelination and tissue destruction in multiple sclerosis.
about
Neuroprotective effect of transplanted human embryonic stem cell-derived neural precursors in an animal model of multiple sclerosis.Modulation of glutamate transport and receptor binding by glutamate receptor antagonists in EAE rat brain.Immunoadsorption patients with multiple sclerosis: an open-label pilot study.C5b-9 complement complex in autoimmune demyelination and multiple sclerosis: dual role in neuroinflammation and neuroprotection.Brain regeneration in physiology and pathology: the immune signature driving therapeutic plasticity of neural stem cellsChemokines and chemokine receptors in multiple sclerosis. Potential targets for new therapies.Preclinical models of multiple sclerosis in nonhuman primates.Age- and gender-specific effects on VDR gene polymorphisms and risk of the development of multiple sclerosis in Tunisians: a preliminary study.Local overexpression of interleukin-11 in the central nervous system limits demyelination and enhances remyelination.Therapeutic effect of transplanted human Wharton's jelly stem cell-derived oligodendrocyte progenitor cells (hWJ-MSC-derived OPCs) in an animal model of multiple sclerosis.Expression of chemokine receptors CCR1 and CCR5 reflects differential activation of mononuclear phagocytes in pattern II and pattern III multiple sclerosis lesions.Transglutaminase-6 is an autoantigen in progressive multiple sclerosis and is upregulated in reactive astrocytes.TNF-induced death of adult human oligodendrocytes is mediated by c-jun NH2-terminal kinase-3.Differential expression of sonic hedgehog immunoreactivity during lesion evolution in autoimmune encephalomyelitis.Immunological study of IFNbeta-1a-treated and untreated multiple sclerosis patients: clarifying IFNbeta mechanisms and establishing specific dendritic cell immunotherapy.
P2860
Q33367115-2FABACF5-7561-442B-8646-6A1305D758D9Q34576582-90EE2C15-CA92-4CF1-844C-57CA00043990Q34650883-AF3ED83E-3A45-4591-8654-B32D0CE7A7C5Q36198492-B820131B-8A73-4734-B5C4-C2824BE18EAAQ36554467-7C016F92-D698-4CA5-82E0-77EAAB15A74CQ36734084-A4E9D95D-79C4-4A12-A378-3E401D1062AAQ37754657-1F1DE99F-28DF-47A1-8B3A-5BC761DBE2EEQ38902896-E2E7A984-5751-4CE9-9E4E-C71CB4075479Q42131323-65BD6C1E-C0B1-44F8-B947-E7FA121E6CD7Q44325852-22426B05-598E-468F-9982-8893CFA8F4C0Q47846958-16E34DFE-1D96-4CDB-8C96-F871B4A65ACEQ48273330-4D177F2A-6330-45BE-A9FE-00ABC36A28B3Q48301208-3563464C-3385-4C1C-96EC-722843332A00Q48887099-445D1362-DBC3-4846-9C04-894415AC94CFQ52563077-CE3FEA94-8836-4291-AC83-D868D1CFF89B
P2860
Mechanisms of demyelination and tissue destruction in multiple sclerosis.
description
2002 nî lūn-bûn
@nan
2002 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Mechanisms of demyelination and tissue destruction in multiple sclerosis.
@ast
Mechanisms of demyelination and tissue destruction in multiple sclerosis.
@en
Mechanisms of demyelination and tissue destruction in multiple sclerosis.
@nl
type
label
Mechanisms of demyelination and tissue destruction in multiple sclerosis.
@ast
Mechanisms of demyelination and tissue destruction in multiple sclerosis.
@en
Mechanisms of demyelination and tissue destruction in multiple sclerosis.
@nl
prefLabel
Mechanisms of demyelination and tissue destruction in multiple sclerosis.
@ast
Mechanisms of demyelination and tissue destruction in multiple sclerosis.
@en
Mechanisms of demyelination and tissue destruction in multiple sclerosis.
@nl
P1476
Mechanisms of demyelination and tissue destruction in multiple sclerosis
@en
P2093
Hans Lassmann
P304
P356
10.1016/S0303-8467(02)00033-1
P577
2002-07-01T00:00:00Z